炎性肌病患者的治疗靶点：当前方法与未来展望 - Suppr

Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.

作者信息

Dalakas Marinos C

机构信息

Neuromuscular Diseases Section, NINDS, NIH, Building 10, Room 4N248, 10 Center Drive MSC 1382, Bethesda, MD 20892-1382, USA.

出版信息

Neuromuscul Disord. 2006 Apr;16(4):223-36. doi: 10.1016/j.nmd.2005.12.008. Epub 2006 Mar 15.

DOI:10.1016/j.nmd.2005.12.008

PMID:16542836

Abstract

摘要

相似文献

Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.

Neuromuscul Disord. 2006 Apr;16(4):223-36. doi: 10.1016/j.nmd.2005.12.008. Epub 2006 Mar 15.

Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.

Folia Med (Plovdiv). 2017 Mar 1;59(1):7-13. doi: 10.1515/folmed-2017-0003.

Therapeutic approaches in patients with inflammatory myopathies.

Semin Neurol. 2003 Jun;23(2):199-206. doi: 10.1055/s-2003-41136.

Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).

J Neurol. 2006 Sep;253 Suppl 5:V64-5. doi: 10.1007/s00415-006-5010-2.

Biologic therapy in the idiopathic inflammatory myopathies.

Rheumatol Int. 2020 Feb;40(2):191-205. doi: 10.1007/s00296-019-04467-6. Epub 2019 Nov 4.

Treatment of idiopathic inflammatory myopathies.

Curr Opin Neurol. 2003 Oct;16(5):569-75. doi: 10.1097/01.wco.0000093099.34793.40.

Polymyositis and dermatomyositis.

Lancet. 2003 Sep 20;362(9388):971-82. doi: 10.1016/S0140-6736(03)14368-1.

The molecular pathophysiology in inflammatory myopathies.

Rev Med Interne. 2004 Jun;25 Suppl 1:S14-6. doi: 10.1016/j.revmed.2004.04.007.

Inflammatory myopathies: evaluation and management.

Semin Neurol. 2008 Apr;28(2):241-9. doi: 10.1055/s-2008-1062267.

High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.

Rheumatology (Oxford). 2020 Nov 1;59(11):3515-3525. doi: 10.1093/rheumatology/keaa273.

引用本文的文献

The anti-inflammatory effect of myrrh ethanolic extract in comparison with prednisolone on an autoimmune disease rat model induced by silicate.

Inflammopharmacology. 2022 Dec;30(6):2537-2546. doi: 10.1007/s10787-022-01042-7. Epub 2022 Aug 5.

Orbital myositis as an initial manifestation of Behcet's disease.

Am J Ophthalmol Case Rep. 2022 Jun 25;27:101630. doi: 10.1016/j.ajoc.2022.101630. eCollection 2022 Sep.

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon.

Pediatr Rheumatol Online J. 2019 Aug 20;17(1):56. doi: 10.1186/s12969-019-0361-2.

Inclusion body myositis: therapeutic approaches.

Degener Neurol Neuromuscul Dis. 2012 May 10;2:43-52. doi: 10.2147/DNND.S19899. eCollection 2012.

Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Neurotherapeutics. 2016 Jan;13(1):132-46. doi: 10.1007/s13311-015-0394-2.

"Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

J Neurol. 2016 Apr;263(4):631-40. doi: 10.1007/s00415-015-7926-x. Epub 2015 Oct 17.

Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.

Pharmacoeconomics. 2015 May;33(5):521-31. doi: 10.1007/s40273-015-0269-8.

Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Clin Exp Immunol. 2014 Dec;178(3):405-15. doi: 10.1111/cei.12445.

The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.

Indian J Pharmacol. 2012 Nov-Dec;44(6):665-71. doi: 10.4103/0253-7613.103235.

Ocular myositis.

Curr Allergy Asthma Rep. 2013 Jun;13(3):315-21. doi: 10.1007/s11882-012-0319-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.

Neuromuscul Disord. 2006 Apr;16(4):223-36. doi: 10.1016/j.nmd.2005.12.008. Epub 2006 Mar 15.

Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.

Folia Med (Plovdiv). 2017 Mar 1;59(1):7-13. doi: 10.1515/folmed-2017-0003.

Therapeutic approaches in patients with inflammatory myopathies.

Semin Neurol. 2003 Jun;23(2):199-206. doi: 10.1055/s-2003-41136.

Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).

J Neurol. 2006 Sep;253 Suppl 5:V64-5. doi: 10.1007/s00415-006-5010-2.

Biologic therapy in the idiopathic inflammatory myopathies.

Rheumatol Int. 2020 Feb;40(2):191-205. doi: 10.1007/s00296-019-04467-6. Epub 2019 Nov 4.

Treatment of idiopathic inflammatory myopathies.

Curr Opin Neurol. 2003 Oct;16(5):569-75. doi: 10.1097/01.wco.0000093099.34793.40.

Polymyositis and dermatomyositis.

Lancet. 2003 Sep 20;362(9388):971-82. doi: 10.1016/S0140-6736(03)14368-1.

The molecular pathophysiology in inflammatory myopathies.

Rev Med Interne. 2004 Jun;25 Suppl 1:S14-6. doi: 10.1016/j.revmed.2004.04.007.

Inflammatory myopathies: evaluation and management.

Semin Neurol. 2008 Apr;28(2):241-9. doi: 10.1055/s-2008-1062267.

High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.

Rheumatology (Oxford). 2020 Nov 1;59(11):3515-3525. doi: 10.1093/rheumatology/keaa273.

引用本文的文献

The anti-inflammatory effect of myrrh ethanolic extract in comparison with prednisolone on an autoimmune disease rat model induced by silicate.

Inflammopharmacology. 2022 Dec;30(6):2537-2546. doi: 10.1007/s10787-022-01042-7. Epub 2022 Aug 5.

Orbital myositis as an initial manifestation of Behcet's disease.

Am J Ophthalmol Case Rep. 2022 Jun 25;27:101630. doi: 10.1016/j.ajoc.2022.101630. eCollection 2022 Sep.

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon.

Pediatr Rheumatol Online J. 2019 Aug 20;17(1):56. doi: 10.1186/s12969-019-0361-2.

Inclusion body myositis: therapeutic approaches.

Degener Neurol Neuromuscul Dis. 2012 May 10;2:43-52. doi: 10.2147/DNND.S19899. eCollection 2012.

Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Neurotherapeutics. 2016 Jan;13(1):132-46. doi: 10.1007/s13311-015-0394-2.

"Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

J Neurol. 2016 Apr;263(4):631-40. doi: 10.1007/s00415-015-7926-x. Epub 2015 Oct 17.

Cost-utility analysis of intravenous immunoglobulin for the treatment of steroid-refractory dermatomyositis in Thailand.

Pharmacoeconomics. 2015 May;33(5):521-31. doi: 10.1007/s40273-015-0269-8.

Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Clin Exp Immunol. 2014 Dec;178(3):405-15. doi: 10.1111/cei.12445.

The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.

Indian J Pharmacol. 2012 Nov-Dec;44(6):665-71. doi: 10.4103/0253-7613.103235.

Ocular myositis.

Curr Allergy Asthma Rep. 2013 Jun;13(3):315-21. doi: 10.1007/s11882-012-0319-7.

Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献